Yahoo

Edwards solidifies TAVR dominance in long-term trial readout

Edwards Lifesciences’ transcatheter aortic valve replacement (TAVR) system has demonstrated positive results in a long-term trial readout, as global demand for the technology increases. The company ...
Medscape

TAVR Comparable to Surgery at 6 Years in Low-Risk Patients, but Reinterventions Increase

Six-year follow-up from a trial comparing surgery with TAVR in low-risk patients showed no difference in major events, but ...
MedPage Today

FDA Approves Sapien 3 TAVR for Asymptomatic Aortic Stenosis

FDA approved the Sapien 3 transcatheter aortic valve replacement (TAVR) platform for treatment of severe aortic stenosis early in the disease process while patients still had no symptoms or other ...
Healio

TAVR for asymptomatic severe aortic stenosis superior to surveillance regardless of age

Please provide your email address to receive an email when new articles are posted on . The benefit of TAVR vs. clinical surveillance for patients with asymptomatic severe aortic stenosis did not vary ...
Nasdaq

Edwards SAPIEN 3 TAVR Delivers Proven Long-term Benefits and Valve Performance, New Data Presented at TCT 2025

SAN FRANCISCO--(BUSINESS WIRE)-- Edwards Lifesciences (NYSE: EW) today announced seven-year data from the PARTNER 3 trial, reaffirming the early and sustained patient benefits of Edwards TAVR. The ...
MedPage Today

First 7-Year Report of Low-Risk TAVR Reassures, With Finish Line Now in Sight

SAN FRANCISCO -- Long-term outcomes after transcatheter aortic valve replacement (TAVR) were looking more and more like those after surgical aortic valve replacement (SAVR) in low-risk patients, ...
Business Wire

Edwards TAVR Receives FDA Approval for Patients With Asymptomatic Severe Aortic Stenosis

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) announced today that the U.S. Food and Drug Administration (FDA) has approved its transcatheter aortic valve replacement (TAVR) therapy ...
Nasdaq

Edwards Lifesciences Says FDA Approved TAVR Therapy For Asymptomatic Severe Aortic Stenosis

(RTTNews) - Edwards Lifesciences Corp. (EW) Thursday said that the U.S. Food and Drug Administration (FDA) has approved its transcatheter aortic valve replacement (TAVR) therapy, the SAPIEN 3 platform ...
Healio

TAVR could be ‘preferred therapeutic option’ over surgery for women

Please provide your email address to receive an email when new articles are posted on . Researchers analyzed outcomes among only women who underwent TAVR or surgery. TAVR was superior to surgery for ...
News Medical

Study evaluates long-term outcomes of TAVR with SAPIEN 3 in intermediate-risk patients

Intermediate-risk patients who received transcatheter aortic valve replacement, known as TAVR, with the latest-generation valve fared better than patients receiving traditional surgical aortic valve ...
FierceBiotech

TCT: Medtronic, Edwards' longer-term TAVR studies continue to perform on par with open-heart surgery

Ongoing long-term studies from the two major producers of transcatheter aortic valve replacements showed the minimally invasive route can continue to perform on par with open-heart surgery in a ...